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Left Ventricular Mechanical Dyssynchrony in
Acute Onset Cardiomyopathy
Association of Its Resolution With Improvements in Ventricular Function
Hidekazu Tanaka, MD, PHD,* Masaki Tanabe, MD, PHD,* Marc A. Simon, MD, MS,*
Randall C. Starling, MD, MPH,† David Markham, MD, MSC,‡ Vinay Thohan, MD,§
Paul Mather, MD, Dennis M. McNamara, MD,* John Gorcsan III, MD*
Pittsburgh and Philadelphia, Pennsylvania; Cleveland, Ohio; Dallas, Texas;
and Winston-Salem, North Carolina
O B J E C T I V E S The purpose of this study was to evaluate mechanical dyssynchrony in patients with
acute onset cardiomyopathy with narrow QRS interval, and its association with improvements in left
ventricular (LV) function.
B A C KG ROUND LV dyssynchrony has been usually studied in patients with chronic heart failure
and wide QRS in the context of cardiac resynchronization therapy.
METHOD S We studied 201 patients enrolled in the IMAC-2 (Inﬂammatory Mediators in Acute
Cardiomyopathy) trial with recent onset nonischemic cardiomyopathy and ejection fraction 40%.
Dyssynchrony was assessed using speckle-tracking velocity vector imaging. Diastolic function was
assessed by mitral inﬂow E and mitral E’ annular velocities (E/E’). A normal control group of 15 normal
volunteers was studied for comparison.
R E S U L T S Although mean QRS was narrow (98 21 ms), 108 (54%) acute cardiomyopathy patients had
signiﬁcant LV dyssynchrony at presentation: opposing wall delay 89 51 ms, versus 35 11 ms in controls,
and 12-site standard deviation 43 23, versus 24 8 ms in controls (p 0.001). Patients with dyssynchrony
had greater degrees of diastolic dysfunction: E/E’ 15 8 versus 12 6 (p 0.05). At 6 months, group mean
ejection fraction improved from23 8% to 40 12% and E/E’ improved from14 7 to 9 5 (both p 0.001).
Dyssynchrony improved from 89  51 ms to 52  35 ms in maximum opposing wall delay, and 43 
23 ms to 32  19 ms in 12-site standard deviation, and the prevalence of dyssynchrony decreased to
12% after 6 months (p  0.001 vs. baseline).
CONC L U S I O N S Mechanical dyssynchrony was observed in a signiﬁcant number of patients with
acute onset cardiomyopathy, despite having a narrow QRS interval. Resolution of dyssynchrony
associated with improvements in LV function occurred in the large majority of these patients. (J Am
Coll Cardiol Img 2011;4:445–56) © 2011 by the American College of Cardiology Foundation
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446lthough acute onset nonischemic cardiomyop-
athy may be clinically devastating, it is asso-
ciated with a wide variety of patient out-
comes (1). A subset of patients may have
chronic manifestations of their disease; however, a
significant number of patients have spontaneous
improvement in ventricular function. Abnormalities
of regional left ventricular (LV) mechanical activa-
tion, known as dyssynchrony, have been observed in
many patients with heart failure, but typically in
See page 457
patients with chronic heart failure and wide QRS
duration studied in the setting of cardiac resynchro-
nization therapy (CRT) (2–6). Patients with acute
onset nonischemic heart failure have been appro-
priately excluded from most CRT clinical trials,
given the potential for subsequent LV recovery
(7–9). Therefore, the clinical implications
of mechanical dyssynchrony in this patient
population are largely unknown. The sec-
ond IMAC (Intervention in Myocarditis
and Acute Cardiomyopathy) trial was a
prospective multicenter investigation of
myocardial recovery in patients with re-
cent onset nonischemic cardiomyopathy
with a LV ejection fraction (EF) 40%,
6 months of symptoms, and a clinical
evaluation consistent with idiopathic car-
diomyopathy or myocarditis. This echo-
cardiographic substudy provided an ideal
opportunity to investigate dyssynchrony in
this unique patient group (10). Accord-
ingly, the objectives of this study were to test the
following hypothesis: 1) that LV dyssynchrony may
be observed in a significant subset of patients with
acute heart failure from acute onset nonischemic
cardiomyopathy with narrow QRS duration; and 2)
that resolution of LV dyssynchrony is related to
improvements in LV systolic and diastolic function
during follow-up. Furthermore, we evaluated the
relationship between the baseline clinical and echo-
cardiographic characteristics and LV recovery at
follow-up and whether baseline characteristics al-
low prediction of LV recovery at follow-up.
M E T H O D S
The study group consisted of 213 patients with acute
onset cardiomyopathy, as part of the IMAC-2 multi-
center study. This protocol was approved by the institu-
tional review board on biomedical research, and all
tion
city
gpatients gave informed consent consistent with this Lprotocol. The patient population consisted of patients
considered eligible on the basis of the following inclusion
criteria: 1) 18 years of age or more; 2) significant systolic
dysfunction, defined as a LVEF of40%; and 3) acute
nset cardiomyopathy, defined as the duration of heart
ailure symptoms 6 months. We excluded patients
ith: 1) coronary artery disease, defined as a single
oronary artery stenosis of a major epicardial vessel
50% or a previous history of myocardial infarction;
) any known cause of cardiomyopathy or a history of
amilial cardiomyopathy; 3) past or present alcohol-
sm; 4) uncontrolled hypertension despite medical
herapy; 5) valvular heart disease; and 6) pericardial
isease. Patients with a clinical history or echocardio-
raphic pattern of apical ballooning, consistent with
ako-tsubo cardiomyopathy were not included (11).
welve patients (6%) were excluded from all subse-
uent analysis because of suboptimal images from
oor echocardiographic windows. Accordingly, the
atient study group consisted of 201 patients. Eighty-
ne patients (40%) were female. The group mean age
as 46 14 years, EF was 23 8% (all40%), and
RS duration was 98 21 ms. No patients had atrial
brillation. The normal control group consisted of 15
olunteers (33% female) ages 41  15 years, with no
istory of cardiovascular disease and completely nor-
al electrocardiograms and 2-dimensional and
oppler echocardiograms (QRS duration 82 16 ms
nd EF 59  4%).
Echocardiography. All echocardiographic studies
ere performed at the time of diagnosis of acute
nset cardiomyopathy and at 6-month follow-up
mean 7  3 months) using commercially available
chocardiography systems: Vivid 7 (GE-Vingmed,
orten, Norway), Sonos 5500, 7500, or iE 33
Philips, Andover, Massachusetts), ACUSON Se-
uoia (Siemens Medical Solutions, Mountain
iew, California), or Aplio 80 or Aplio Artida
Toshiba Medical Systems, Tokyo, Japan) (12).
igital routine grayscale 2-dimensional cine loops
ere obtained at frame rates of 40 to 90 Hz (mean
0  15 Hz) from standard apical 4-chamber,
-chamber, and long-axis views, at a depth of 12 to
0 cm during apnea for grayscale imaging. Sector
idth was optimized to allow for complete myocar-
ial visualization while maximizing frame rate.
ain settings were adjusted for routine clinical
rayscale 2-dimensional imaging to optimize endo-
ardial definition. The Digital Imaging and Com-
unications in Medicine (DICOM) formatted file
mages were then exported to a personal computer
nd analyzed off line with customized software. TheA B B R E V I A T I O N S
A N D A C R O N YM S
A atrial wave velocity
CI confidence interval
CRT cardiac resynchroniza
therapy
E early diastolic wave velo
E’ early diastolic mitral
annular velocity
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447Simpson rule using manual tracing of digital images
(13). Recovery of LV function in acute onset
cardiomyopathy was defined as absolute EF in-
crease 10% at 6-month follow-up.
The pulsed-wave Doppler-derived transmitral
elocity and digital color tissue Doppler-derived
itral annular velocity were obtained in 147 pa-
ients from apical 4-chamber views for assessment
f diastolic function (14–16). The early diastolic
E), atrial (A) wave velocities, and the E-wave
eceleration time were measured using pulsed-wave
oppler recording. Color tissue Doppler-derived
arly diastolic velocity (E’) was obtained from lateral
itral annulus. The E/E’ was calculated to estimate
V filling pressure (Fig. 1). Restrictive mitral dia-
tolic filling pattern was defined as E/A ratio 2, a
deceleration time 160 ms, and an E/E’ 12 (14).
Dyssynchrony analysis. Longitudinal dyssynchrony
was assessed from basal and mid-levels in apical
4-chamber, 2-chamber, and long-axis views for a
total of 12 sites, using Velocity Vector Imaging
(VVI [Siemens Medical Solutions, and TomTec
Imaging Systems, Munich, Germany). The VVI
used a series of unique B-mode pixel tracking
algorithms, as described previously in detail (10,17).
Briefly, VVI required manual endocardial tracing of
the mid-wall from a single frame on a routine
digital cine loop, then automatically tracked motion
of the tissue/cavity border and the periodicity of
Figure 1. Mitral Inﬂow and Mitral Annular Velocities Using Dop
Mitral inﬂow and mitral annular velocities using Doppler echocardio
with an ejection fraction of 21%. (Top panels) Diastolic dysfunction
strated. (Bottom panels) Six months later, this patient’s ejection fra
tion, resolution of restrictive ﬁlling, and decrease in estimated ﬁlling
E’  early diastolic mitral annular velocity.motion to calculate and display regional velocity
vectors. A point of reference was placed by the user at
the left ventricle apex for the calculation of the
longitudinal velocities. Figure 2 shows an example
case of velocity vector images and corresponding
time-velocity plots in an acute onset cardiomyopathy
patient at presentation and 6-month follow-up. Dys-
synchrony was assessed in 3 ways: 1) maximum
opposing wall delay in time-to-peak systolic velocity
among 3 apical views; 2) maximum difference in
time-to-peak systolic velocity between any 2 of 12
sites; and 3) the standard deviation of 12-site
time from QRS onset to peak systolic velocities
(12-site standard deviation) (6,18). On the basis
of our previous observations in a group of patients
undergoing CRT, our pre-defined cutoff for sig-
nificant dyssynchrony was 75 ms in opposing
wall delay in time to peak systolic velocity in 1
view among the 3 apical views (10). For a more
complete dyssynchrony analysis, we also deter-
mined maximal difference in time to peak veloc-
ities from any view, and 12-site standard devia-
tion. In our laboratory, the interobserver and
intraobserver variabilities were 4  9% and 3 
7% for difference in time to peak velocity by VVI
(10), and 8  8% and 6  6% for EF (19),
espectively.
Statistical analysis. All group data were presented as
mean  SD. Paired t tests were used for group
Echocardiography
phy in a patient with acute onset cardiomyopathy who presented
trictive ﬁlling, and elevated estimated ﬁlling pressures are demon-
n improved to 49%, and he had improvement in diastolic func-
essures. A  atrial wave velocity; E  early diastolic wave velocity;pler
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448comparison between baseline and 6-month follow-
up. Wilcoxon matched-pairs signed-rank tests and
McNemar test were additionally used to compare
New York Heart Association functional class, and
nominal binary variables such as prevalence of
significant dyssynchrony and restrictive filling be-
tween baseline and 6-month follow-up, respec-
tively. Unpaired t tests were used for group com-
parisons between patients with acute onset
cardiomyopathy and normal controls. Because nor-
mality assumptions were not satisfied, the Mann-
Whitney U test was used to evaluate dyssynchrony
parameters and E/E’. Proportional differences were
evaluated with Fisher exact test or the chi-square
test as appropriate. Correlation analysis was per-
formed using linear regression and expressed as a
Pearson correlation coefficient. Optimal cutoff val-
ues for association of LV volumes with recovery at
6-month follow-up were determined by receiver-
operator characteristics curve analysis. Statistical
Figure 2. Velocity Vector Imaging in a Patient With Acute Onse
Velocity vector imaging in a patient with acute onset cardiomyopat
Time-velocity curves were extracted from respective left ventricular
line indicates basal-septum, blue line indicates mid-septum, purple
demonstrate an opposing wall peak systolic velocity delay (arrow)
later, this patient’s EF improved to 49%, and there was 20 ms of
ECG  electrocardiogram.significance was p  0.05. aR E S U L T S
The study group consisted of 201 patients with
complete data sets consisting baseline and 6-month
follow-up LV volume, EF, and dyssynchrony data.
Group mean follow-up data were 7  3 months
after presentation. A subgroup of 147 patients had
data available for diastolic function analysis at
baseline and follow-up. Overall, VVI was possible
in 96% of 5,004 attempted segments from 216
subjects (baseline and 6-month follow-up for 201
patients and baseline for 15 normal controls) with
technically adequate images. Only 4% of segments
were eliminated.
Patient clinical data. Thirty patients were New York
eart Association functional class I, 91 were class
I, 70 were class III, and 10 were class VI at baseline
Table 1). Conventional pharmacological therapy at
he time of baseline included angiotensin-
onverting enzyme inhibitor in 162 patients (81%),
rdiomyopathy Who Presented With EF of 23%
ho presented with ejection fraction (EF) of 23%. (Top panels)
al and mid- segments from the apical 4-chamber view (yellow
indicates basal-lateral, and black line indicates mid-lateral), and
00 ms, consistent with dyssynchrony. (Bottom panels) Six months
osing wall delay, demonstrating resolution of dyssynchrony.t Ca
hy w
bas
line
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449blockers in 161 (80%), diuretics in 148 (74%), and
spironolactone in 61 (30%) (Table 1). Eighteen
patients (9%) required inotropic support, 2 (1%)
required intra-aortic balloon pump support, and 4
(2%) required ventricular assist device at the time of
initiation of the pharmacological therapy (Table 1).
At 6-month follow-up, 83 patients were New York
Heart Association functional class I, 96 were class
II, 21 were class III, and 1 was class VI (p  0.001
vs. baseline).
Baseline LV function and dyssynchrony. Although
RS was narrow (98  21 ms), acute onset
ardiomyopathy was associated with evidence of
echanical dyssynchrony; opposing wall delay of
9 51 ms (95% confidence interval [CI]: 82 to 96
ms) versus 35  11 ms (95% CI: 29 to 41 ms) in
ontrols, maximum delay of 118  60 ms (95% CI:
09 to 126 ms) versus 67  19 ms in controls (95%
I: 56 to 78 ms), and 12-site standard deviation of
3  23 ms (95% CI: 40 to 46 ms) versus 24  8
ms (95% CI: 20 to 28 ms) in controls (all p 0.001
vs. controls) (Table 1). One-hundred and eight
patients (54%) had evidence of significant LV
dyssynchrony at baseline, defined as 75 ms in
opposing wall delay, in contrast to none of the
normal control subjects. Patients with acute onset
cardiomyopathy also had an increased prevalence of
diastolic dysfunction among the 147 patients with
diastolic function data available compared with
controls: E/E’ 14  7 versus 6  1 (p  0.001 vs.
ontrols) (Table 1). Forty-two patients (29%) had
vidence of restrictive filling. In addition, patients
ith mechanical dyssynchrony had greater diastolic
ysfunction, E/E’ 15  8 versus 12  6, and
revalence of restrictive filling, 37% versus 20%
all p  0.05 vs. no-dyssynchrony heart failure
roup), even though EF was similar at 23  8%
ersus 24  9% in the no-dyssynchrony group.
o significant correlations were seen between
aseline LV dyssynchrony and baseline E’ and the
-wave deceleration time.
Changes in LV function and dyssynchrony after
6-month follow-up. At 6-month follow-up, group
ean EF improved from 23  8% to 40  12%,
nd-diastolic volume decreased from 199  65 ml
o 164  66 ml, and end-systolic volume decreased
rom 156  65 ml to 103  59 ml (all p  0.001
s. baseline) (Fig. 3). Prevalence of significant
yssynchrony was reduced from 54% of patients at
aseline to only 12% at 6-month follow-up (p 
.001 vs. baseline) (Fig 4). Details of improvement
n dyssynchrony were as follows: from 89  51 ms
95% CI: 82 to 96 ms) to 52  35 ms (95% CI: 47o 57 ms) in opposing wall delay, from 118 60 ms
95% CI: 109 to 126 ms) to 86  49 ms (95% CI:
9 to 93 ms) in maximum delay, and from 43  23
s (95% CI: 40 to 46 ms) to 32  19 ms (95% CI:
9 to 35 ms) in 12-site standard deviation (all p 
.001 vs. baseline). Diastolic function by E/E’ also
mproved from 14  7 to 9  5, and prevalence of
estrictive filling was reduced from 30% to 4%
verall (all p  0.001 vs. baseline) (Fig. 5).
Clinical and echocardiographic characteristics and LV
recovery. One hundred and forty-three patients
(71%) had evidence of LV recovery, defined as
absolute EF increase10% in EF units at 6-month
follow-up, and 58 patients (32%) had continued LV
dysfunction. Although approximately one-half of
these patients had significant dyssynchrony at pre-
sentation, overall QRS duration was narrow, and
Table 1. Baseline Clinical and Echocardiographic Characteristics
of the Study Population
Acute Onset
Cardiomyopathy
(n  201)
Normal C
(n 
Age, yrs 46 14 41
Female 81 (40) 4 (2
Heart rate, beats/min 84 16 61
QRS duration, ms 98 21 82
End-diastolic volume, ml 199 72 79
End-systolic volume, ml 156 65 33
Ejection fraction, % 23 8 58
E/E’ 14 7 6
Dyssynchrony, ms
Opposing wall delay 89 51 35
Maximum delay 118 60 67
12-site standard deviation 43 23 24
Prevalence of dyssynchrony 108 (54) 0 (0
NYHA functional class
I 30 (15)
II 91 (45)
III 70 (35)
IV 10 (5)
Pharmacological therapy
ACEI 162 (81)
ARB 24 (12)
Beta-blocker 161 (80)
Diuretics 148 (74)
Spironolactone 61 (30)
Inotropic support 18 (9)
IABP 2 (1)
VAD 4 (2)
Values are mean  SD or n (%). The E/E’ was assessed in a subset of 147 p
cardiomyopathy.
ACEI angiotensin-converting enzyme inhibitor; ARB angiotensin-receptor b
wave velocity; E’  early diastolic mitral annular velocity; IABP  intra-aortic
signiﬁcant; NYHA  New York Heart Association; VAD  ventricular assist deviontrols
15) p Value
16 NS
7) NS
9 0.01
16 0.01
15 0.001
6 0.001
4 0.001
1 0.001
11 0.001
19 0.001
8 0.001
) 0.001
atients with acute onset
locker; E early diastolic
balloon pump; NS  notonly 22 (6%) had QRS 120 ms. The QRS
volu
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450duration was not associated with measures of LV
dyssynchrony at baseline or follow-up. Improve-
ments in LV synchrony were associated with
improvements in LVEF and with improvements
Figure 3. Dot Plots of Acute Onset Cardiomyopathy
Dot plots of acute onset cardiomyopathy patients at presentation (
ments were observed in ejection fraction (left panel), end-diastolic
Figure 4. Dyssynchrony at Baseline and After 6-Month Follow-U
(A) A decrease in the prevalence of signiﬁcant dyssynchrony from 5
strated (p  0.001). (B) Improvement in individual dyssynchrony pa
ms to 52  35 ms in opposing wall delay (left), from 118  60 ms
32  19 ms in 12-site standard deviation (right).in E/E’: r  0.45 and r  0.53 for opposing
wall delay, and r  0.39 and r  0.52 for
12-site standard deviation, respectively (all p 
0.001) (Fig. 6).
line) and after 6-month follow-up. Overall, signiﬁcant improve-
mes (middle panel), and end-systolic volumes (right panel).
at presentation to only 12% at 6-month follow-up is demon-
eters at 6-month follow-up are shown, as follows: from 89  51
6  49 ms in maximum delay (middle), and from 43  23 ms tobasep
4%
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451Patients with continued LV dysfunction, com-
pared with patients with LV recovery, were more
likely to have larger baseline LV volumes (LV
end-diastolic volume 224 76 ml vs. 187 67 ml,
and LV end-systolic volume 176 66 ml vs. 146
62 ml; all p  0.001 vs. patients with LV recovery)
(Table 2). When indexed for body surface area,
receiver-operator characteristic curve analysis re-
vealed end-diastolic volume index cutoff of 100
ml/m2 had a sensitivity of 62% and specificity of
66% for predicting an increase in EF of 10% in
EF units from baseline (Fig. 7). Similarly, an
end-systolic volume index cutoff of 75 ml/m2 had a
ensitivity of 59% and specificity of 64% for pre-
icting an increase in EF of10% in EF units from
aseline. No significant differences were seen in
aseline age, sex, QRS duration, EF, and any
yssynchrony parameters (opposing wall delay,
aximum delay, 12-site standard deviation, and
revalence of dyssynchrony) between patients with
V recovery and patients with continued LV dys-
unction (Table 2).
D I S C U S S I O N
This is the first study to demonstrate the association
of LV mechanical dyssynchrony with systolic and
diastolic dysfunction in acute onset cardiomyopathy
at presentation and its resolution at 6-month
follow-up. Dyssynchrony was seen in a significant
number of patients with acute onset cardiomyopa-
thy; despite having a narrow QRS duration, its
resolution was related to improvements in LV
systolic and diastolic function. The LV recovery,
defined as improvement in EF, occurred in a
significant number of these acute onset cardiomy-
opathy patients and occurred most often in those
with smaller LV volumes at presentation. These
data may be considered to reflect the state-of-the-
art LV recovery rate for nonischemic patients
treated at heart failure centers.
Previous clinical studies have demonstrated
that patients with acute onset cardiomyopathy
have a widely variable degree of improvement in
LV function during subsequent follow-up (1).
Although roughly one-third of patients have
dramatic restoration of LV function during the
first year after presentation, the remainder is left
with chronic cardiomyopathy, heart failure, and a
guarded prognosis. Although cardiac remodeling
has been attributed mainly to structural changes
in cardiac myocytes and gene expression (20,21),
the mechanism for reverse remodeling and recov-ery is less well understood (22). Furthermore,
there are currently no adequate markers to predict
recovery in newly diagnosed patients. This cur-
rent study supports the continuum of remodeling
and reverse remodeling to be a dynamic process
in many patients with acute cardiomyopathy.
Although baseline clinical characteristics, EF,
and dyssynchrony parameters were not found to
be predictive of LV recovery, patients with less
remodeled or smaller LV volumes at presentation
were found to have the highest probability of LV
functional recovery. Simon et al. (23) also re-
cently observed that patients with a less dilated
left ventricle on presentation with severe heart
failure (6.0 cm) have the greatest incidence of
LV recovery on LV assist device therapy (23).
LV mechanical dyssynchrony has emerged as an
important mechanism contributing to the progres-
sion of heart failure and LV remodeling, and it
appears to also play a pathophysiologic role in heart
failure (2,6,24–27). LV dyssynchrony has been
observed in many patients with heart failure, but
typically in patients with chronic heart failure and
wide QRS duration associated with a positive re-
sponse to CRT (2,5,6,19,25–27). It was observed
that 20% to 30% of chronic heart failure patients
with QRS duration 120 ms did not have LV
dyssynchrony (28,29). Conversely, it was demon-
strated that 20% to 50% of patients with a narrow
QRS complex (120 ms) may also exhibit LV
Figure 5. Diastolic Function at Baseline and After 6-Month Follo
Estimation of ﬁlling pressures by E/E’ improved from 14  7 to 9 
of restrictive ﬁlling from 30% to 4% (*p  0.001 vs. baseline). E  e
velocity; E’  early diastolic mitral annular velocity.w-Up
5, and prevalence
arly diastolic wavedyssynchrony, although it is inconclusive whether
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452these patients may benefit from CRT (28,30,31).
More recently, dyssynchrony by speckle-tracking
echocardiography has been shown to be associated
with response to CRT in patients with chronic
heart failure and borderline QRS duration 100 to
130 ms (27). Dyssynchrony has also been shown to
be associated with long-term survival in patients
with chronic heart failure and routine indications
for CRT (26,32,33). Takemoto et al. (34) demon-
strated that medical therapy improves LV contrac-
tile function and dyssynchrony in dilated cardiomy-
opathy patients with chronic heart failure and
normal QRS duration. Thus, most of the clinical
trials studying LV dyssynchrony have focused on
patients with chronic heart failure, and little is
known about LV dyssynchrony patients with acute
heart failure. In this study, we demonstrated that
dyssynchrony was seen in a significant number of
patients with acute heart failure from acute onset
nonischemic cardiomyopathy, despite having a nar-
row QRS duration. In addition, we observed reso-
lution of LV dyssynchrony to be associated with
improvements in LV function during follow-up in
acute cardiomyopathy.
Diastolic dysfunction, specifically abnormali-
ties of distensibility, filling, or relaxation, may
play an important role in patients with heart
failure (15,16,35). Restrictive diastolic filling is
particularly common in patients with severe LV
Figure 6. Improvements in Mechanical Dyssynchrony and EF an
Associations of improvements in mechanical dyssynchrony with imp
with acute onset cardiomyopathy, from baseline presentation to 6-
sured by opposing wall delay were associated with improvements
stolic wave velocity; E’  early diastolic mitral annular velocity.systolic failure and traditionally is a marker for apoor prognosis (36). In this study, patients with
acute onset cardiomyopathy had diastolic dys-
function and high prevalence of restrictive filling
at presentation. In addition, we observed that
patients with dyssynchrony had more diastolic
dysfunction than patients without dyssynchrony.
Of note, both groups had comparable systolic
function. Therefore, more severe diastolic dys-
function in dyssynchronous patients can most
likely be ascribed to the mechanical dyssyn-
chrony. In an animal model with right ventricular
pacing–simulating left bundle branch block, dys-
synchronous wall motion was shown to lead to
increase LV filling pressure (37). Previous inves-
tigators (38,39) suggested that LV dyssynchrony
has an effect on early diastolic filling through
dyssynchronous relaxation and is often the cause
of prolonged isovolumic relaxation time. Color
tissue Doppler parameters derived from mitral
annular velocity seem to be less load dependent
than conventional transmitral or pulmonary vein
flow variables, and E’ behaves as a relatively
preload-independent parameter of relaxation
(15,40). In addition, E/E’ was proposed as an
estimate of LV filling pressures, and this ratio has
been properly validated in a variety of patients
(15,16,35).
We assessed 3 different longitudinal dyssyn-
chrony indices in this study that have been
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453CRT (6,10,18,19,41,42). VVI is an angle-
independent speckle-tracking method to extract
quantitative regional time-motion data. An ad-
vantage of the VVI software is that the analysis
approach using the DICOM file format is uni-
form despite different vendors’ echocardiography
machines. The PROSPECT (Predictors of Re-
sponse to CRT) study used 3 different vendors’
software approaches for dyssynchrony analysis
which likely resulted in higher variability (43).
The velocity vectors superimposed on the routine
2-dimensional image facilitate a rapid visual assess-
ment of synchronicity. According to our previous
work with VVI, a 75 ms baseline dyssynchrony,
defined as maximum opposing wall delay in time-to-
peak systolic velocity among 3 apical views, predicted
response to cardiac resynchronization therapy with
85% sensitivity and 80% specificity (10).
Study limitations. A limitation of this study is that
t focused on the echocardiographic and nonin-
asive hemodynamic findings in these patients.
e were unable to address the relationship be-
ween the dyssynchrony and humoral or hemo-
ynamic factors. Other limitations were that we
ere unable to determine potential relationships
f LV function and dyssynchrony to mitral insuf-
ciency, brain natriuretic peptide levels, or renal
unction in these patients. It could be considered
limitation that it was not possible to establish a
elationship between the duration of heart failure
nd LV recovery, as all patients were specifically
ithin the narrow window of heart failure onset
6 months by enrollment criteria. All patients
ad significant coronary artery disease excluded
y coronary angiography to establish the diagno-
is of nonischemic cardiomyopathy; however,
ardiac magnetic resonance for the diagnosis of
brosis was not part of this study. A limitation of
he image acquisition used for VVI was a rela-
ively slow frame rate compared with other tech-
iques, such as tissue Doppler. However, we (10)
nd other investigators (44 – 46) have demon-
trated the utility of VVI for clinical setting at
hese frame rates, and VVI analysis at a faster
rame rate is being developed. Another limitation
f VVI is the user interface required for endocar-
ial border tracing. Care must be taken to man-
ally fine tune the endocardial border tracing if
he endocardial tracking is unfavorable. This
tudy focused on longitudinal shortening by VVI
o assess LV dyssynchrony. The largest body of
ublications on LV dyssynchrony and predicting
f response to CRT is represented by LV longi- sudinal shortening velocities from the apical
iews (2,6,10,18,19,41). However, the recent
ulticenter study of the predictors of responders
o CRT, known as the PROSPECT study, ex-
osed technical difficulties with echocardio-
raphic dyssynchrony analysis, in particular tissue
oppler, and concluded that no single echocar-
iographic dyssynchrony measure was highly pre-
ictive of response to CRT (43). Although prob-
ems with technical acquisition and variability
nterfered with precise interpretation of the re-
ults of PROSPECT study, the conclusion was
hat routine clinical selection criteria for CRT,
ncluding QRS duration, have not yet been re-
laced. Speckle-tracking methods for dyssyn-
hrony analysis, such as VVI, were not evaluated
n the PROSPECT study and have a technical
dvantage over tissue Doppler as being angle
ndependent (47,48). Another limitation of the
resent study is that radial dyssynchrony was not
valuated (4,5,12,49,50). A final limitation is that
nvasive hemodynamic measurement of LV dia-
tolic function was not performed in this study.
lthough cardiac catheterization remains the
Table 2. Baseline Characteristics of Patients With Ventricular Re
and Continued Dysfunction
Baseline Variable
LV Recovery
(n  143)
Continued LV D
(n  58
Age, yrs 47 14 44 1
Female 59 (41) 22 (38
Heart rate, beats/min 83 17 86 1
Systolic blood pressure, mm Hg 112 17 110 2
Diastolic blood pressure, mm Hg 72 13 69 1
QRS duration, ms 97 19 102 2
End-diastolic volume, ml 191 68 219 7
End-systolic volume, ml 149 62 171 6
Ejection fraction, % 22 8 24 7
Dyssynchrony, ms
Opposing wall delay 87 51 95 5
Maximum delay 117 59 120 6
12-site standard deviation 43 23 43 2
Prevalence of dyssynchrony 77 (54) 31 (53
E/E’ 14 7 14 7
Pharmacological therapy
ACEI 115 (80) 47 (81
ARB 18 (13) 6 (10
Beta-blocker 114 (80) 47 (81
Diuretics 103 (72) 45 (78
Spironolactone 40 (28) 21 (36
Values are mean  SD or n (%). Deﬁnition of left ventricular recovery: absolute
10%. E/E’ was assessed in a subset of 147 patients with acute onset cardiom
LV  left ventricular; other abbreviations as in Table 1.covery
ysfunction
) p Value
4 NS
) NS
4 NS
1 NS
2 NS
7 NS
8 0.05
9 0.05
NS
1 NS
3 NS
1 NS
) NS
NS
) NS
) NS
) NS
) NS
) NS
ejection fraction increase
yopathy.tandard technique for direct assessment of LV
U
S
frac
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454filling pressure, E/E’ has been a useful noninva-
sive parameter for prediction of LV filling pres-
sure in patients with heart failure (15,16,35).
Clinical implications. The present study reports that
significant mechanical dyssynchrony may be ob-
served in approximately one-half of patients with
recent onset nonischemic cardiomyopathy and
low EF, despite having a narrow QRS. Dyssyn-
chrony resolves within 6 months in the large
majority of these patients receiving conventional
medical therapy, and is associated with improve-
ments in EF. Although baseline mechanical dys-
Figure 7. Receiver-Operating Characteristic Curves
Baseline end-diastolic volume index (blue line) and end-systolic vo
an increase in ejection fraction by at least 10% in absolute ejection191–213. 2002;105:438–45.tients with relatively smaller, less remodeled left
ventricles at presentation had the greatest prob-
ability of recovery. These observations support a
watchful waiting approach, rather than early
device therapy with cardioverter-defibrillator im-
plantation or CRT soon after presentation in this
patient population.
Reprint requests and correspondence: Dr. John Gorcsan III,
niversity of Pittsburgh, Scaife Hall 564, 200 Lothrop
treet, Pittsburgh, Pennsylvania 15213-2582. E-mail:
index (pink line) with sensitivities and speciﬁcities for predicting
tion units. AUC  area under the curve; CI  conﬁdence interval.synchrony was not predictive of outcome, pa- gorcsanj@upmc.edu.R E F E R E N C E S
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